Company
MoonLake Immunotherapeutics (MLTX)
Standardized SEC financial data for MoonLake Immunotherapeutics — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001821586 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-74.7%
ROIC
-438.9%
Free cash flow
-$196.0M
Debt / equity
0.24×
Current ratio
9.27×
EPS (diluted)
$-3.53
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| R&D expense | $35.5M | $42.0M | $31.8M | $112.8M | $202.9M |
| SG&A expense | $18.0M | $23.0M |
Balance sheet
| USD | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.0M | — | $39.5M | $451.2M | $180.4M | $334.5M |
| Total current assets |
Cash flow
| USD | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$35.2M | — | -$55.9M | -$42.8M | -$116.6M | -$196.0M |
| Capital expenditures |
Get MLTX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MLTX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MLTX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"